RELATIONSHIP BETWEEN SERUM CONCENTRATION AND DOSE OF VALPROIC ACID DURING MONOTHERAPY IN ADULT OUTPATIENTS

被引:13
|
作者
TISDALE, JE
TSUYUKI, RT
OLES, KS
PENRY, JK
机构
[1] HENRY FORD HOSP,DEPT PHARM SERV,DETROIT,MI 48202
[2] UNIV BRITISH COLUMBIA,FAC PHARMACEUT SCI,VANCOUVER V6T 1W5,BC,CANADA
[3] ROYAL COLUMBIAN HOSP,NEW WESTMINSTER,BC,CANADA
[4] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT NEUROL,WINSTON SALEM,NC 27103
关键词
VALPROIC ACID; SERUM CONCENTRATION; DOSE RATIOS; MONOTHERAPY; ADULTS;
D O I
10.1097/00007691-199210000-00013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The relationship between serum concentration and dose of valproic acid (VPA) is reported to be variable and inconsistent. However, studies evaluating this relationship have included individuals of varying ages and patients receiving potentially interacting medications. In this study, the relationship between VPA serum concentration and dose was evaluated in a homogeneous patient population. Medical records of 60 adult outpatients with epilepsy receiving VPA monotherapy were examined retrospectively for VPA dose (milligrams per kilogram) and corresponding serum VPA concentrations. A significant linear correlation was found in the relationship between VPA dose and serum concentration among all patients (r = 0.63; p < 0.01). However, considerable interindividual variability in this ratio was demonstrated [coefficient of variation (CV) = 28.99%], and the ratio was significantly dependent on VPA dose. In three selected individual patients, a significant linear correlation was also demonstrated in the VPA serum concentration:dose relationship over time (r = 0.91, 0.94, 0.96; p < 0.05 for all three patients) with substantially less variability (CV = 10.2-14.6%) and without significant dose dependency, suggesting that this parameter may be useful for guiding VPA dosage adjustment and monitoring patient compliance. Further study is required to evaluate the utility of the serum concentration:dose ratio in monitoring VPA therapy.
引用
收藏
页码:416 / 423
页数:8
相关论文
共 50 条
  • [1] RELATIONSHIP BETWEEN VALPROIC ACID DOSAGE, PLASMA-CONCENTRATION AND CLEARANCE IN ADULT MONOTHERAPY PATIENTS WITH EPILEPSY
    GIDAL, BE
    PITTERLE, ME
    SPENCER, NW
    MALY, MM
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1995, 20 (04) : 215 - 219
  • [2] Relationship between clinical efficacy and serum concentration of 10-hydroxycarbazepine in patients with epilepsy on oxcarbazepine monotherapy or bitherapy with valproic acid
    Kalpachki, Rosen
    Kalinov, Krasimir
    Svinarov, Dobrin
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 490 - 490
  • [3] The correlation between carbamazepine and valproic acid monotherapy with serum adiponectin and carnitine
    Fatma Şimşek
    Mustafa Ceylan
    Ahmet Kızıltunç
    İbrahim İyigün
    Acta Neurologica Belgica, 2021, 121 : 1823 - 1830
  • [4] The correlation between carbamazepine and valproic acid monotherapy with serum adiponectin and carnitine
    Simsek, Fatma
    Ceylan, Mustafa
    Kiziltunc, Ahmet
    Iyigun, Ibrahim
    ACTA NEUROLOGICA BELGICA, 2021, 121 (06) : 1823 - 1830
  • [5] Safety range of free valproic acid serum concentration in adult patients
    Tseng, Yu-Ju
    Huang, Shih-Ying
    Kuo, Chih-Hsuan
    Wang, Chen-Yu
    Wang, Kuo-Chuan
    Wu, Chien-Chih
    PLOS ONE, 2020, 15 (09):
  • [6] Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients
    Gibbs, Haley G.
    Zimmerman, David E.
    Shermock, Kenneth M.
    Clarke, William
    Mirski, Marek A.
    Lewin, John J., III
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (02) : 121 - 126
  • [7] Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy
    Mei, Shenghui
    Feng, Weixing
    Zhu, Leting
    Yu, Yazhen
    Yang, Weili
    Gao, Baoqin
    Wu, Xiaojuan
    Zhao, Zhigang
    Fang, Fang
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2017, 51 : 22 - 26
  • [8] Evaluation of the valproic acid-lamotrigine pharmacokinetic interaction: Relationship to valproate dose and serum concentration in healthy volunteers
    Gidal, BE
    Sheth, RD
    Parnell, J
    Pitterle, M
    NEUROLOGY, 2001, 56 (08) : A331 - A331
  • [10] Low serum biotinidase activity in children with valproic acid monotherapy
    Schulpis, KH
    Karikas, GA
    Tjamouranis, J
    Regoutas, S
    Tsakiris, S
    EPILEPSIA, 2001, 42 (10) : 1359 - 1362